Ramsay Health Care shares ward off pain from credit rating cut

The private hospital operator has taken a hit to its investment grade credit rating.

| More on:
Stressed thoughtful old female general practitioner doctor physician looking in distance, considering difficult medical problem solution or illness treatment, working on computer in clinic office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care Ltd (ASX: RHC) shares are in the green on Friday despite news of a credit rating downgrade from the Fitch Ratings agency.

Ramsay shares are currently trading for $51.66, up 0.27% on Friday.

The company released a statement regarding the rating agency's downgrade today.

Let's take a look.

Ramsay shares still rising despite ratings downgrade

Fitch downgraded the investment grade credit rating ascribed to Ramsay's Funding Group from BBB/Negative to BBB-/Stable.

The Funding Group refers to Ramsay Health Care Limited and all subsidiaries, excluding Ramsay Santé.

Ramsay Health Care said:

The change in rating is not expected to impact Ramsay's ability to access funding and liquidity in the
future.

The financial impact of this change in rating on the Company's $1.5bn Sustainability Linked
Loan is a 10bp increase in interest costs.

Ramsay reconfirms that it expects its FY24 net interest expense (including AASB 16 lease costs) to be in the range of $570-600m2.

As of 30 June, Ramsay's leverage under its banking covenants was 3.2×3, which is below the covenant threshold of 4x. Ramsay says it is aiming to reduce its leverage below 2.5x.

Ramsay's interest coverage ratio was 7.35x, which is well above the banking covenant of greater than 3x.

Proposed sale of Sime Darby

Ramsay and its joint venture partner, Sime Darby Berhad are actively exploring selling their Asia-based business, Ramsay Sime Darby Health Care.

Ramsay announced this decision on 28 June, saying:

The decision has been reached following the receipt of significant inbound interest in RSD at values that are in shareholders' interests to explore, noting that there is no certainty that a sale process will result in a completed transaction.

Investors appeared supportive of the idea with Ramsay shares ascending 4.77% on the day of the news.

Since then, Ramsay says they have received "a number of non-binding indicative offers".

The company added: "A select number of parties are now in a phase 2 due diligence process expected to conclude towards the end of October".

The funds from a sale would be used to pay down debt.

Ramsay expects to announce the outcome of its deliberations before its annual general meeting (AGM).

No date for the AGM has been set as yet.

Recent history of Ramsay shares

The Ramsay Health Care share price is down 20% in the year to date.

By comparison, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 3% over the same period.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »